awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33628778-1B7D6C7A-A0A3-493D-8544-448A7E7EDD88
Q33628778-1B7D6C7A-A0A3-493D-8544-448A7E7EDD88
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33628778-1B7D6C7A-A0A3-493D-8544-448A7E7EDD88
Phase II trial of pemetrexed plus bevacizumab for second-line therapy of patients with advanced non-small-cell lung cancer: NCCTG and SWOG study N0426.
P2860
Q33628778-1B7D6C7A-A0A3-493D-8544-448A7E7EDD88
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33628778-1B7D6C7A-A0A3-493D-8544-448A7E7EDD88
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0575939eba712e7896a547847332ce2e524e905e
P2860
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.